Hemanshu Patel
About Hemanshu Patel
Hemanshu Patel is the Region Associate Director of the MSL Community Oncology East Team at Bristol Myers Squibb, with over 30 years of experience in nursing and oncology.
Current Position at Bristol Myers Squibb
Hemanshu Patel currently serves as the Region Associate Director MSL-Community Oncology East Team at Bristol Myers Squibb. In this role, he is responsible for overseeing the medical science liaison team within the community oncology sector in the eastern region. His duties involve coordinating with oncology professionals and enhancing treatment strategies through scientific expertise and communication.
Previous Roles at Bristol Myers Squibb
Before his current position, Hemanshu Patel worked as an Immuno-Oncology Nurse Liaison at Bristol Myers Squibb from 2015 to 2021. In this role, he facilitated communication and collaboration between the company and oncology nurses, advancing immuno-oncology treatments. His six-year tenure in this position helped bridge the gap between research and clinical practice, focusing on patient care and treatment efficacy.
Experience at Memorial Sloan Kettering Cancer Center
In 2015, Hemanshu Patel served as an Advanced Practice Nurse (APN) at Memorial Sloan Kettering Cancer Center in Basking Ridge. Although his tenure was brief, lasting three months, his role involved intensive patient care and collaboration within a leading cancer treatment institution. This position further deepened his experience in oncology nursing and patient management.
Academic Background in Nursing
Hemanshu Patel obtained his Master of Science in Nursing (MSN) degree from The College of New Jersey, where he studied from 2007 to 2011. Prior to this, he earned his Bachelor's Degree in Nursing from Rutgers University – Camden, where he studied from 1986 to 1990. His foundational education in nursing set the stage for his extensive career in oncology and medical research.
Clinical and Research Experience
Hemanshu Patel has amassed over 30 years of experience in the nursing and oncology fields, including significant roles in clinical and research settings. He worked on phase I clinical research trials at The Cancer Institute of New Jersey, with a focus on medical and GYN oncology gained during his decade-long tenure at Cooper University Health Care. His transition from clinical roles to a liaison role in immuno-oncology demonstrates his adaptability and commitment to advancing cancer care.